Cite Filings / CLDI / 0001641172-25-025645

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Calidi Biotherapeutics, Inc. Filed 2025-08-27 Acc 0001641172-25-025645

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-04 SCHEDULE 13G Statement of Beneficial Ownership
2025-08-27 SCHEDULE 13G Statement of Beneficial Ownership
2025-08-27 3 Initial Statement of Ownership
2025-08-25 4 Director bought 75,000 shares at $2.00 ($150,000)
2025-08-25 4 Chief Executive Officer bought 25,000 shares at $2.00 ($50,000)
2025-08-25 4 Director bought 125,000 shares at $2.00 ($250,000)
2025-05-15 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…